# Pushpak Kedia

> Pushpak Kedia is a seed investor at Peak XV Partners backing Biotechnology. See 2 investments, round sizes, portfolio and contact details. Updated Nov 2026.

- Type: Angel Investor
- Fund: [Peak XV Partners](https://shizune.co/investors/profile/sequoia-india-2)
- Location: Bengaluru, India
- Total investments: 2
- Last investment: Oct 2026
- Lead investor: 50%
- Last updated: Nov 2026
- LinkedIn: https://www.linkedin.com/in/pushpak-kedia/

Pushpak Kedia is a seed investor at Peak XV Partners in Bengaluru focused on Biotechnology and Artificial Intelligence. Pushpak Kedia - Vice President @ Peak XV Partners

## Contacts

5 contacts available for Pushpak Kedia: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/pushpak-kedia-1bfb?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Artificial Intelligence | 2 | 100% |
| SaaS | 1 | 50% |
| Medical | 1 | 50% |
| Biopharma | 1 | 50% |

11 industries tracked in total.

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BioStack | BioStack Platforms develops data infrastructure and simulation environments for healthcare and drug discovery AI. The company builds proprietary preclinical and clinical data pipelines that connect longitudinal, multimodal medical data such as EHRs, imaging, ECGs, labs, notes, audio, and outcomes. It structures this information intomachine-learning-ready datasets and workflow-aligned simulation environments rather than static text corpora. These environments support post-training, reinforcement learning, and multi-agent reasoning for medical AI systems. BioStack Platforms serves AI labs, biotechnology startups, pharmaceutical teams, and data providers that need domain-specific datasets, causal inference support, and robust reward models. Its offerings are used to test, evaluate, and train medical AI models on real-world clinical workflows before deployment in practice. | $9.5M | Seed | Oct 22, 2026 | https://www.getbiostack.com/ |
| Delineate | Delineate process research publications, patents, and databases to deliver evidence-based insights that guide, focusing on clarity and impact. Transform research papers into actionable data. Delineate system sifts through vast libraries of research, pinpointing papers that match Delineate specific requirements. Delineate automatically convertscomplex information from plots, tables, figures, and text into structured datasets, enabling rapid data exploration and analysis and expert guidance. |  | Seed |  | https://delineate.pro |

2 of 2 investments shown.

## Co-investors
- [Afore Capital](https://shizune.co/investors/profile/afore-capital) — VC Fund, 1 deal together
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 1 deal together
- [Emerson Collective](https://shizune.co/investors/profile/emerson-collective) — VC Fund, 1 deal together
- [Streamlined](https://shizune.co/investors/profile/streamlined-ventures) — VC Fund, 1 deal together
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund, 1 deal together
- [Verdict Capital](https://shizune.co/investors/profile/verdict-capital-1d52) — VC Fund, 1 deal together

## About Peak XV Partners

VC Fund · Bengaluru, India

Peak XV is a leading full-stack venture and growth investment firm anchored on India and the broader APAC region with a multi-stage strategy spanning seed to growth and a dedicated operating platform built to support founders beyond capital.

5 contacts available at Peak XV Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Ishaan Mittal | Managing Director | https://shizune.co/investors/profile/ishaan-mittal |
| Pushpak Kedia | Vice President | https://shizune.co/investors/profile/pushpak-kedia-1bfb |
| Ajey Gore | Operating Partner - Technology | https://shizune.co/investors/profile/ajey-gore |
| Arnav Sahu | Investment Partner | https://shizune.co/investors/profile/sanchit-narang |
| Ashish Agrawal | Managing Director | https://shizune.co/investors/profile/ashish-agrawal |

## Similar investors

### Similar stage
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Pushpak Kedia invest in?

Pushpak Kedia invests primarily in Biotechnology, Artificial Intelligence and SaaS startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Pushpak Kedia?

Public channels for Pushpak Kedia include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Pushpak Kedia last invest?

The most recent investment recorded for Pushpak Kedia closed in Oct 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
